Professional Media briefs

Share this article:
Quadrant HealthCom's The Female Patient launched a new website at femalepatient.com. The site features a new look, easier navigation and access to audiocasts, videocasts and mobile apps, along with an improved registration/subscription process allowing users to customize, change and update preferences.

Thomson Reuters acquired GeneGo, a San Diego-based firm that provides biology and disease information, analytics and decision support services for pharma R&D. GeneGo will be folded into Thomson Reuters' Healthcare & Science business. The acquisition bolsters Thomson Reuters' drug pipeline competitive intelligence, patents and chemistry offerings with GeneGo's expertise in science, particularly on biologics. In addition to its San Diego headquarters, GeneGo has offices in Moscow and Michigan.

Elsevier dropped the “Cytogenetics” from its Cancer Genetics and Cytogenetics journal, and tapped a new editor-in-chief. The first issue with the shortened title, Cancer Genetics, goes out this month, with Jaclyn Biegel at the helm. The title change reflects a broader aim and scope for the journal, with a new focus on diagnostic applications and genetic predisposition of cancer, according to a statement.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what ...

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...